Atopic dermatitis (eczema) trials in United States

In United States 77 Also abroad 251

77 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Effects of Treatments on Atopic Dermatitis
Where
Bethesda
Age
2 years to 50 years
People
130
Run by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
See details and how to joinNCT01631617
Phase 3Taking people
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Where
Birmingham, Charleston, Jacksonville, Macon, Miami, Norfolk, North Little Rock, Palo Alto, Portland, Sacramento, San Diego, Tampa, Tulsa, Waterford
Age
6 months to 11 years
People
195 worldwide
Run by
LEO Pharma
See details and how to joinNCT06311682 · EU 2023-503630-44-00
Early phase 1Enrolling by invitation
Thera-Clean® Microbubbles System in Patients With Skin Diseases
Where
Chicago
Age
2 years and over
People
20
Run by
Northwestern University
See details and how to joinNCT07050810
Phase 1Taking people
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
Where
Bethesda
Age
12 years to 120 years
People
20
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07262983
No phaseTaking people
Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
Where
Caledonia, Columbus, Henderson, Las Vegas, Lee's Summit, Longview, Los Angeles, Missouri City, Morgantown, New York, Norfolk, Phoenix, Portsmouth, Rockville, South Jordan, Tampa
Age
12 years to 89 years
People
450
Run by
Castle Biosciences Incorporated
See details and how to joinNCT07645820
No phaseTaking people
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Where
Pittsburgh
Age
18 years and over
People
200
Run by
University of Pittsburgh
See details and how to joinNCT00177268
Phase 1Taking people
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Where
Birmingham, Miami, North Charleston, North Little Rock, San Antonio, Union City, West Hills, Weston
Age
18 years to 65 years
People
160 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT07527923 · EU 2025-524205-32-00
Phase 3Taking people
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
Where
Arlington, Bakersfield, Birmingham, Boise, Bryant, Camp Hill, Dallas, East Syracuse, Fountain Valley, Hialeah, Huntington Beach, Hunt Valley, Indianapolis, Laguna Niguel, Los Angeles, Macon, Marietta, Memphis, Miami, Miami Lakes, Northridge, Orlando, Phoenix, Portland, Santa Ana, Southlake, Sugar Land, Tampa, Troy, Tulsa, Ypsilanti
Age
12 years and over
People
1,375 worldwide
Run by
Pfizer
See details and how to joinNCT07783425 · EU 2026-525743-32-00
Phase 3Taking people
Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis
Where
Birmingham, Bryant, Chicago, Miami Lakes
Age
6 years and over
People
415
Run by
Arcutis Biotherapeutics, Inc.
See details and how to joinNCT07916480
No phaseTaking people
Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Where
Bethesda
Age
2 years to 100 years
People
530
Run by
National Human Genome Research Institute (NHGRI)
See details and how to joinNCT00605878
Phase 1Taking people
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
Where
Anaheim, Miami, Philadelphia, San Diego, Troy
Age
18 years to 70 years
People
119 worldwide
Run by
Pfizer
See details and how to joinNCT06564389 · EU 2025-524150-34-00
Phase 3Taking people
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Where
Birmingham, Charleston, Greenville, Indianapolis, Jacksonville, Meridian, North Little Rock, San Antonio, San Diego, St Louis
Age
2 years to 11 years
People
450 worldwide
Run by
Pfizer
See details and how to joinNCT06807281 · EU 2023-509124-18-00
Phase 2Taking people
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Where
Huntington Beach, Lorain, Los Angeles, Margate, Mayfield Heights, Miami, Northridge, Philadelphia, Phoenix, Pittsburgh, Santa Monica, Scottsdale, The Bronx
Age
18 years to 64 years
People
165 worldwide
Run by
Pfizer
See details and how to joinNCT07216027 · EU 2025-522965-31-00
No phaseTaking people
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
Where
Bethesda
Age
18 years to 75 years
People
300
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT04864886
Phase 2Taking people
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Where
Boardman, Bowling Green, Charleston, Coral Gables, Dallas, Detroit, Douglasville, Fountain Valley, Frisco, Jacksonville, Los Angeles, Margate, Mason, Mill Creek, Nashville, New York, Pittsburgh, Portland, Rockville, San Antonio, Skokie, Troy, Wilmington
Age
18 years and over
People
350 worldwide
Run by
Apogee Therapeutics, Inc.
See details and how to joinNCT07003425
Phase 1Taking people
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
Where
New Haven
Age
18 years to 65 years
People
133 worldwide
Run by
Pfizer
See details and how to joinNCT07660731 · EU 2026-526260-21-00
No phaseTaking people
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Where
Albuquerque, Ann Arbor, Auburn Hills, Bakersfield, Bay City, Birmingham, Bolivar, Bountiful, Caledonia, Dallas, Detroit, Doral, Falls Church, Fargo, Fort Worth, Fremont, Gilbert, Huntersville, Kirksville, Las Vegas, Lincoln, Los Angeles, Macon, Marion, Mason, Mill Creek, Montgomery, Normal, North Chicago, North Miami Beach, Northridge, Oakland, Pflugerville, Phoenix, Pittsburgh, Pomona, Portsmouth, San Diego, Seattle, Spartanburg, Springville, Sugar Land, Warwick, Waterford, Wheat Ridge, Winston-Salem
Age
12 years and over
People
1,000 worldwide
Run by
Sanofi
See details and how to joinNCT07290803
Phase 2Taking people
Cardamom and Topical Roseomonas in Atopic Dermatitis
Where
Bethesda
Age
2 years to 100 years
People
120
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT06096857
No phaseTaking people
Natural History and Genetics of Food Allergy and Related Conditions
Where
Bethesda
Age
1 day to 99 years
People
1,800
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT02504853
Phase 2Taking people
A Study Evaluating TRIV-573 in Atopic Dermatitis
Where
Bay City, Boardman, Boca Raton, Camp Hill, Fountain Valley, Indianapolis, Los Angeles, Miami, Myrtle Beach, San Antonio, Spokane
Age
18 years to 75 years
People
90 worldwide
Run by
Triveni Bio
See details and how to joinNCT07782333
Phase 3Enrolling by invitation
A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Where
Bay City, Bellaire, Birmingham, Boise, Boston, Charleston, Chicago, Fairborn, Farmington, Fountain Valley, Jacksonville, Lebanon, Los Angeles, Milwaukee, North Little Rock, Owensboro, Phoenix, Sacramento, San Antonio, Tampa, Ypsilanti
Age
6 months to 18 years
People
338 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05735483 · EU 2022-501478-21-00
Phase 1Taking people
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Where
College Station, Fair Lawn, Miami, Plainfield, San Antonio, South Jordan
Age
18 years to 65 years
People
125
Run by
Arcutis Biotherapeutics, Inc.
See details and how to joinNCT07453602
No phaseTaking people
Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Where
New York
Age
13 years to 17 years
People
40
Run by
Weill Medical College of Cornell University
See details and how to joinNCT07746427
Phase 3Taking people
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Where
Auburn Hills, Boca Raton, Boise, Bowling Green, Clifton, Fountain Valley, Lafayette, Los Angeles, Macon, New York, Normal, North Little Rock, Oklahoma City, Omaha, Owensboro, Phoenix, St. Petersburg, Tampa, Wilmington
Age
12 years and over
People
510 worldwide
Run by
Nektar Therapeutics
See details and how to joinNCT07690371 · EU 2025-524925-42-00
Phase 2Taking people
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Where
New York
Age
12 years and over
People
56
Run by
Icahn School of Medicine at Mount Sinai
See details and how to joinNCT07242638